These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 10883676

  • 1. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA, Gregory WM, Bowman A, Anderson ED, Levack P, Forouhi P, Leonard RC.
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, Rosenman J, Ollila DW, Graham M.
    Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [Abstract] [Full Text] [Related]

  • 3. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR, Romero AO, Pérez JE, Lacava JA, Domínguez ME, Rodríguez R, Barbieri MR, Romero Acuña LA, Romero Acuña JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA.
    Cancer J Sci Am; 1998 Jun; 4(2):125-31. PubMed ID: 9554929
    [Abstract] [Full Text] [Related]

  • 5. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R, Osaki A, Tanabe K, Toge T.
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [Abstract] [Full Text] [Related]

  • 6. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [Abstract] [Full Text] [Related]

  • 7. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1062-73. PubMed ID: 15234040
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
    Pierga JY, Mouret E, Diéras V, Laurence V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Vincent-Salomon A, Scholl S, Extra JM, Asselain B, Pouillart P.
    Br J Cancer; 2000 Dec 15; 83(11):1480-7. PubMed ID: 11076657
    [Abstract] [Full Text] [Related]

  • 9. Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast.
    Schwartz GF, Meltzer AJ, Lucarelli EA, Cantor JP, Curcillo PG.
    J Am Coll Surg; 2005 Sep 15; 201(3):327-34. PubMed ID: 16125064
    [Abstract] [Full Text] [Related]

  • 10. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
    Pinder SE, Murray S, Ellis IO, Trihia H, Elston CW, Gelber RD, Goldhirsch A, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Golouh R, Rudenstam CM, Castiglione-Gertsch M, Gusterson BA.
    Cancer; 1998 Oct 15; 83(8):1529-39. PubMed ID: 9781946
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
    Borgquist S, Jögi A, Pontén F, Rydén L, Brennan DJ, Jirström K.
    Breast Cancer Res; 2008 Oct 15; 10(5):R79. PubMed ID: 18808688
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy.
    Buchholz TA, Tu X, Ang KK, Esteva FJ, Kuerer HM, Pusztai L, Cristofanilli M, Singletary SE, Hortobagyi GN, Sahin AA.
    Cancer; 2005 Aug 15; 104(4):676-81. PubMed ID: 15981280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.